FITC-Labeled Siglec-2 His Tag: The "Classic Starter Probe" for B-Cell Detection
FITC-Labeled Siglec-2 His Tag is a cost-effective and widely applicable recombinant protein detection probe designed for the key B-cell marker CD22 (Siglec-2).
- Recent Advances
- Product Information
Recent Advances
FITC-Labeled Siglec-2 His Tag is a cost-effective and widely applicable recombinant protein detection probe designed for CD22 (Siglec-2), a key marker of B cells. Compared to versions equipped with advanced fluorescent dyes or complex functional modules, this probe is positioned as a standardized, easily accessible, and reliable basic research tool that meets the core needs of most laboratories for routine B cell identification, population analysis, and CD22 expression detection. By combining the glycan recognition domain of CD22 with the classic His purification tag and the widely used FITC fluorescent reporting system, it provides a low-threshold, highly compatible "classic entry-level probe" for B cell immunology research, hematological tumor diagnosis, and teaching experiments.
I. Overview: Concise Structure and Functional Positioning
This protein is a structurally simple and functionally focused recombinant fusion probe, designed to meet basic detection needs. It consists of three clear functional components:
Siglec-2/CD22 Binding Module
The core of the probe is the extracellular sialic acid-binding domain of human CD22 protein. CD22 is a B cell-specific inhibitory receptor, and its extracellular domain can specifically recognize and bind α2,6-linked sialic acid glycans. This module retains the ability to bind to sialylated glycoproteins (such as BCR and CD45) on the B cell surface, serving as a "probe" for specific glycosylation states of B cells.
His Tag
The fused polyhistidine tag serves two primary functions:
Convenient One-Step Purification: Through nickel affinity chromatography, low-cost and high-efficiency protein production and purification are achieved, ensuring batch-to-batch consistency and activity, which is key to maintaining its cost-effectiveness.
Basic Immobilization Capability: Facilitates the immobilization of the probe on nickel-coated plates or chips for developing simple ELISA assays or preliminary binding kinetic analyses.
FITC Fluorescent Label
Fluorescein isothiocyanate (FITC) is stably covalently linked to the protein. FITC emits green fluorescence when excited by 488 nm laser light. Its advantages as a classic choice include:
Unparalleled Device Compatibility: Compatible with 100% of FITC detection channels, from basic teaching-level flow cytometers to high-end clinical analyzers, and from ordinary fluorescence microscopes to confocal systems, ensuring method transferability and widespread use.
Lowest Experimental Threshold and Cost: FITC-labeled reagents are typically the lowest in cost, with the most mature and simple operational protocols, making them ideal for budget-limited laboratories, large-scale preliminary screening experiments, or undergraduate/graduate teaching.
Abundant Controls and Reference Data: Decades of application have accumulated vast amounts of experimental parameters (e.g., voltage, compensation values), facilitating quick adoption by beginners and result comparison.
Design Philosophy
This probe is a "basic teaching tool" and "standardized workhorse" in B cell research. The CD22 binding domain is a "standard ruler" for identifying specific glycosylation "signatures" on B cell surfaces; FITC is a "classic display" that presents measurement results in the most universal and economical "green readout"; and the His tag is a "simple calibration handle" that ensures this "ruler" can be stably and standardizedly produced. Its goal is to become a "standard" reagent that any immunology laboratory can equip and easily use.
II. Core Mechanism: Direct and Stable Basic Detection
The core application mechanism of this probe is straightforward, focusing on providing stable and reliable one-step detection results.
1. Glycan-Dependent Specific Binding
Labeling B Cell Populations: When the probe is co-incubated with a lymphocyte suspension, in the presence of calcium ions, its CD22 domain binds to α2,6-sialic acid modifications on glycoproteins on the B cell surface. Since other lymphocytes (T cells, NK cells) lack abundant such modifications, effective labeling and gating of B cell populations are achieved.
Reflecting B Cell Glycosylation Status: The fluorescence intensity not only indicates the abundance of CD22 ligands but also indirectly reflects B cell activation states (activated B cells exhibit altered glycosylation patterns), making it a simple tool for studying B cell surface glycosylation biology.
2. One-Step Direct Detection
Ultra-Simple Operation: Incubate-wash-analyze, completed in three steps. No secondary antibody is needed, significantly reducing experimental time and minimizing variability and background due to multi-step operations.
Stable and Reliable Results: Direct labeling avoids batch-to-batch differences and cross-reactivity issues associated with secondary antibodies, providing results that more directly reflect CD22 ligand binding.
3. Compatibility with Complex Sample Processing
Suitable for Surface Marking After Intracellular Staining: In experiments requiring intracellular cytokine or nuclear protein staining, fixation and permeabilization steps may disrupt epitopes of many surface antigens. However, FITC fluorescence signals are relatively stable, and the probe's binding is based on glycan recognition rather than a single protein epitope, sometimes remaining usable after mild fixation, offering more possibilities for multicolor experiments (conditions need optimization).
Usable for Preliminary Cell Sorting: Combined with flow sorters, FITC-positive B cell populations can be sorted for subsequent culture or analysis.
III. Downstream Applications: Covering Routine Research and Diagnostic Needs
This probe is a practical tool for meeting daily B cell-related research and basic clinical detection needs.
1. Basic Immunology and Teaching Experiments
Basic Lymphocyte Subset Typing: Combined with FITC-CD3, PE-CD19 antibodies, etc., used in undergraduate or graduate teaching experiments to teach students flow cytometry gating logic and the basic distinction between T, B, and NK cells.
Basic Research on B Cell Development and Activation: Used to analyze changes in B cell population size and proportion in different tissues (bone marrow, spleen, lymph nodes) or under different stimulation conditions.
2. Clinical Immunophenotyping and Hematological Tumor Screening
Peripheral Blood Lymphocyte Subset Analysis: In hospital laboratories or basic clinical research, serves as a supplementary or validation method for B cell counting. Although CD19 antibodies are more commonly used, this probe provides an alternative detection perspective based on B cell functional characteristics (specific glycosylation).
Preliminary Screening for B Cell Tumors Like Chronic Lymphocytic Leukemia: Can be used to detect B cell population expansion in diseases like CLL. Its binding pattern may differ from CD19 antibodies, sometimes providing additional information.
Immunodeficiency Disease Screening: Assists in evaluating B cell counts in peripheral blood of patients with primary or secondary immunodeficiency.
3. Preliminary Screening in Drug Development and Evaluation
Preliminary Assessment of Immunosuppressant Effects on B Cells: In drug safety evaluations or immunopharmacology studies, quickly assesses the impact of candidate compounds on B cell proportions in animal or human peripheral blood.
Tool for Glycobiology-Related Drug Research: Serves as an in vitro binding or competition assay tool for drugs targeting the sialic acid-Siglec pathway (e.g., for autoimmune diseases or inflammation).
4. Entry-Level Tool for Glycobiology Research
Studying the Effects of Sialidases or Glycosylation Inhibitors: After treating cells (e.g., with sialidase to remove terminal sialic acids or glycosylation inhibitors), detecting changes in binding signals using this probe is a simple entry-level experiment for studying protein glycosylation functions and their regulation.
IV. Future Prospects: Enduring Value of Classic Tools in Standardization and Education
Amid rapid advancements in high-end technologies, the value of this classic probe remains undiminished, continuing to shine in specific areas.
As a Reference for Standardization and Quality Control
Due to its standardized production and signal stability, it can serve as an internal or cross-laboratory reference probe for flow cytometry standardization and quality control, monitoring instrument status and staining protocol stability.
Promoting Accessibility and Reproducibility in Basic Research
Its low cost and high compatibility help promote and popularize basic B cell immunology research globally, particularly in resource-limited research institutions, enhancing scientific accessibility and data comparability.
Core Teaching Tool for Online Education and Practical Training
In increasingly popular online virtual experiment courses or simulations, the FITC-CD22 probe is often selected as a典型案例 to demonstrate flow cytometry principles and data analysis due to its classic nature.
Performance Benchmark for New Detection Technologies
When developing new B cell detection methods based on novel principles (e.g., fluorescence-free techniques), this probe's results can serve as a traditional "fluorescence gold standard" to validate the accuracy and reliability of new technologies.
Supporting Large-Scale Epidemiological or Cohort Studies
In large cohort studies requiring basic immunophenotyping of tens of thousands of samples, its cost-effectiveness, reliability, and automation compatibility make it an attractive high-value option.
Product Information












